دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان- قیمت ویژه : 2,400,000تومان
پکیج دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
- :
قیمت : 1,500,000 تومان- قیمت ویژه : 750,000تومان
Correction to “Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies�
doi : 10.1002/acr2.70086
Whole-Blood RNA Sequencing Profiling of Patients With Rheumatoid Arthritis Treated With Tofacitinib
doi : 10.1002/acr2.11761
Association of Soluble Immune Checkpoint Molecules PD1 and 4-1BB With CTLA-4Ig Treatment Response in Early Rheumatoid Arthritis
doi : 10.1002/acr2.70069
Giant Aortic Aneurysm in Refractory Behçet’s Disease Shrank with Tocilizumab Treatment: A Case Report
doi : 10.1002/acr2.70071
Clinical Images: Magnetic resonance imaging changes of bone marrow edema in the hands in Raynaud phenomenon
doi : 10.1002/acr2.70088
Assessing Disease Activity in Pediatric Chronic Nonbacterial Osteomyelitis: A Proposal for Composite Scoring, Including Inactivity Measures
doi : 10.1002/acr2.70061
Clinical Images: Löffler endocarditis: a rare cardiac manifestation of eosinophilic granulomatosis with polyangiitis
doi : 10.1002/acr2.70056
Identification of miR-190a-5p and miR-26b-5p as Potential microRNA Biomarkers for Psoriatic Arthritis
doi : 10.1002/acr2.70014
Association of Knee Pain Frequency and Severity with Quadriceps Strength but Not Rate of Decline Over Four Years
doi : 10.1002/acr2.70067
Asymptomatic hypertension and bilateral renal artery stenosis in Takayasu arteritis
doi : 10.1002/acr2.70077
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll-Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study
doi : 10.1002/acr2.70059
Clinical Images: Interstitial lung disease in Sjögren disease in association with systemic sclerosis
doi : 10.1002/acr2.70076
